CO-AX Accelerator @ Sahlgrenska Science Park welcomes healthtech innovators for autumn 2024 intake
Building on its legacy of nurturing impactful healthtech innovations, the CO-AX Accelerator at Sahlgrenska Science Park is now accepting applications for its autumn 2024 intake. This call is directed towards innovators and startups who are leveraging technology to address global health challenges.
As a leading healthtech accelerator, CO-AX offers a unique platform for visionary startups to transform their ideas into impactful healthcare solutions. The program is dedicated to advancing healthtech, medtech, biotech and deeptech startups that are pushing the boundaries of healthcare innovation.
So far, CO-AX has supported >140 companies, which have collectively raised over €100 million in capital, with 32% of these companies now operating internationally.
Key benefits for participants
Participants in the CO-AX program will gain access to a comprehensive suite of support, including:
Tailored coaching: Expert guidance from seasoned business advisors, industry experts and mentors.
Market access: Opportunities for testing, verification, and market entry.
Global growth pathways: Strategic roadmaps for international expansion and capital acquisition.
Regulatory guidance: Support in navigating regulatory and compliance landscapes.
Exposure and proximity to world-class clinicians and researchers: Direct access to insights from healthcare professionals and researchers.
Collaborative community: Access to events, seminars, co-working spaces and shared labs.
Emma Hallenberg, Operations Manager for CO-AX at Sahlgrenska Science Park, says, ““CO-AX is the ideal environment for entrepreneurs committed to making a meaningful impact in healthcare. Our specialized expertise, extensive networks and vibrant community empower startups to unlock their full potential and accelerate their growth. We’re looking for innovative tech startups with a clear vision for addressing unmet needs in global healthcare.”
